MRK vs WFC: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Wells Fargo & Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
Merck & Co., Inc. · Healthcare
$119.07
-4.0% upside to fair value
Grade D
High Quality
VS
Wells Fargo & Company · Financial Services
$81.52
+30.6% upside to fair value
Grade B
QuantHub Verdict
WFC has more upside to fair value
(+30.6%).
WFC trades at a lower forward P/E
(11.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
WFC |
| Current Price |
$119.07 |
$81.52 |
| Fair Value Estimate |
$114.30 |
$106.49 |
| Upside to Fair Value |
-4.0%
|
+30.6%
|
| Market Cap |
$294.4B |
$250.7B |
| Forward P/E |
16.2x
|
11.9x
|
| EV / EBITDA |
12.6x
|
16.7x
|
| Price / Sales |
4.5x
|
2.0x
|
| Price / FCF |
23.8x
|
-13.2x
|
| Revenue Growth YoY |
+5.0%
|
+7.3%
|
| Gross Margin |
81.5%
|
64.5%
|
| Operating Margin |
41.2%
|
20.5%
|
| Return on Equity |
36.2%
|
12.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.2%
|
—
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, particularly oncology and vaccines. The company benefits from a strong business quality characterized by a durable competitive moat, high gross margins of 81.5%, and a robust return on equity of 36.2%. Despite these strengths, the stock is currently fairly valued but slightly overvalued by 4% relative to its…
Wells Fargo & Company is a diversified financial services firm operating primarily in consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. The company benefits from a seasoned CEO with extensive industry experience and has made significant progress in regulatory compliance and operational efficiency, including lifting its asset cap in 2025.…
Accumulation Zones
| Metric |
MRK |
WFC |
| Zone Low |
$85.72 |
$79.87 |
| Zone High |
$97.16 |
$90.52 |
| In Buy Zone? |
No
|
Yes
|